These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers. Farshbaf M; Mojarad-Jabali S; Hemmati S; Khosroushahi AY; Motasadizadeh H; Zarebkohan A; Valizadeh H J Control Release; 2022 May; 345():371-384. PubMed ID: 35301054 [TBL] [Abstract][Full Text] [Related]
4. RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells. Lee SG; Kim CH; Sung SW; Lee ES; Goh MS; Yoon HY; Kang MJ; Lee S; Choi YW Int J Nanomedicine; 2018; 13():3263-3278. PubMed ID: 29910614 [TBL] [Abstract][Full Text] [Related]
5. Lactoferrin/CD133 antibody conjugated nanostructured lipid carriers for dual targeting of blood-brain-barrier and glioblastoma stem cells. Zhao C; Zhu X; Yang H; Tan J; Gong R; Mei C; Cai X; Su Z; Kong F Biomed Mater; 2024 Aug; 19(5):. PubMed ID: 39134023 [TBL] [Abstract][Full Text] [Related]
6. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy? Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462 [TBL] [Abstract][Full Text] [Related]
7. Cysteine-Functionalized Nanostructured Lipid Carriers for Oral Delivery of Docetaxel: A Permeability and Pharmacokinetic Study. Fang G; Tang B; Chao Y; Xu H; Gou J; Zhang Y; Xu H; Tang X Mol Pharm; 2015 Jul; 12(7):2384-95. PubMed ID: 25974386 [TBL] [Abstract][Full Text] [Related]
8. Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel. Sun B; Luo C; Li L; Wang M; Du Y; Di D; Zhang D; Ren G; Pan X; Fu Q; Sun J; He Z Colloids Surf B Biointerfaces; 2016 Jul; 143():47-55. PubMed ID: 27011346 [TBL] [Abstract][Full Text] [Related]
9. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells. Kim CH; Kang TH; Kim BD; Lee TH; Yoon HY; Goo YT; Choi YS; Kang MJ; Choi YW Int J Pharm; 2020 Jun; 583():119393. PubMed ID: 32376445 [TBL] [Abstract][Full Text] [Related]
10. Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity. Safwat S; Ishak RAH; Hathout RM; Mortada ND Drug Dev Ind Pharm; 2017 Jul; 43(7):1112-1125. PubMed ID: 28276784 [TBL] [Abstract][Full Text] [Related]
11. SN38 loaded nanostructured lipid carriers (NLCs); preparation and in vitro evaluations against glioblastoma. Shirazi AS; Varshochian R; Rezaei M; Ardakani YH; Dinarvand R J Mater Sci Mater Med; 2021 Jun; 32(7):78. PubMed ID: 34191134 [TBL] [Abstract][Full Text] [Related]
12. Indinavir-Loaded Nanostructured Lipid Carriers to Brain Drug Delivery: Optimization, Characterization and Neuropharmacokinetic Evaluation. Nasiri M; Azadi A; Zanjani MRS; Hamidi M Curr Drug Deliv; 2019; 16(4):341-354. PubMed ID: 30674257 [TBL] [Abstract][Full Text] [Related]
13. Glioblastoma multiforme targeted delivery of docetaxel using bevacizumab-modified nanostructured lipid carriers impair in vitro cell growth and in vivo tumor progression. Di Filippo LD; Lobato Duarte J; Hofstätter Azambuja J; Isler Mancuso R; Tavares Luiz M; Hugo Sousa Araújo V; Delbone Figueiredo I; Barretto-de-Souza L; Miguel Sábio R; Sasso-Cerri E; Martins Baviera A; Crestani CC; Teresinha Ollala Saad S; Chorilli M Int J Pharm; 2022 Apr; 618():121682. PubMed ID: 35307470 [TBL] [Abstract][Full Text] [Related]
14. pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation. Kim CH; Sa CK; Goh MS; Lee ES; Kang TH; Yoon HY; Battogtokh G; Ko YT; Choi YW Int J Nanomedicine; 2018; 13():6661-6675. PubMed ID: 30425481 [TBL] [Abstract][Full Text] [Related]
15. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy. Song S; Mao G; Du J; Zhu X Drug Deliv; 2016 May; 23(4):1404-8. PubMed ID: 26203687 [TBL] [Abstract][Full Text] [Related]
16. Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema. Gao S; Tian B; Han J; Zhang J; Shi Y; Lv Q; Li K Int J Nanomedicine; 2019; 14():6135-6150. PubMed ID: 31447556 [No Abstract] [Full Text] [Related]
17. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers with exceptional gastrointestinal stability and inhibition of P-gp efflux for improved oral delivery of tilmicosin. Zhang Q; Yang H; Sahito B; Li X; Peng L; Gao X; Ji H; Wang L; Jiang S; Guo D Colloids Surf B Biointerfaces; 2020 Mar; 187():110649. PubMed ID: 31767412 [TBL] [Abstract][Full Text] [Related]
20. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment. Wang D; Wang C; Wang L; Chen Y Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]